The contract offers HALO, the leading infant protection system for over a decade, and RoamAlert, the next generation in patient-wandering protection. Using state-of-the-art skin-sensing RFID tag technology, HALO helps health care facilities prevent infant abductions, accidental baby-switching, and medical equipment theft and loss while providing a safe work environment for staff. It can also be used to protect paediatric patients, monitor flight-risk patients, and track patients from admission to discharge.
RoamAlert is the most complete patient wandering system available today helping nursing homes and assisted living facilities provide the best possible patient, staff, and medical equipment protection and tracking. Both products are part of the company's line of state-of-the-art RFID solutions for the healthcare industry now found in over 3000 installations worldwide.
"Working with Novation means more health care facilities have the opportunity to benefit from the overall peace of mind and cost savings HALO and RoamAlert deliver", stated Kevin McLaughlin, Chief Executive Officer, VeriChip Corporation. "We're honoured to be a Novation supplier and look forward to working with them."
eXI's announcement signals the second health care purchasing group relationship for the company, building on a contract signed with another organisation in September 2003. With both agreements in place, the company's solutions are offered with the two largest purchasing groups within United States health care.
Based in Irving, Texas, Novation was established in January 1998 through a combination of the supply programmes of VHA and UHC, two national health care alliances. Novation serves the purchasing needs of more than 2500 members and affiliates of VHA and UHC. These organisations used Novation contracts to purchase more than $23 billion in supplies in 2004.
VeriChip is a wholly owned subsidiary of Applied Digital and the only company to provide both implanted and external RFID security solutions for people, their assets, and their environments. From the world's first and only FDA-cleared, human-implantable RFID microchip to the only patented active RFID tag with skin-sensing capabilities, VeriChip leads the way in next-generation RFID technologies. Today, over 3000 installations worldwide in health care, security, industrial, and government markets benefit from both the protection and cost savings VeriChip's innovation delivers. More news on VeriChip can be found in the VMW June 2005 article Applied Digital's VeriChip Corporation introduces improved patient wander protection.